Warning: Use of undefined constant SCRIPT_DEBUG - assumed 'SCRIPT_DEBUG' (this will throw an Error in a future version of PHP) in /homepages/37/d13561511/htdocs/tradingpattern.net/wp-includes/formatting.php on line 4144

Dr. Reddy’s Laboratories

Dr. Reddy’s Laboratories is an integrated pharmaceutical company and operates in business segments such as global generics, active ingredients and proprietary products.

Dr Reddy’s March quarter results were higher-than-estimated with revenue growing 22.8% year-over-year, driven by robust growth of 67.6% in U.S. generics and 25.7% in Russia and CIS. The launch of generic fexofenadine pseudoephedrine during the quarter lifted U.S. growth. However, Indian formulations grew only 5.1% year-over-year.

Adjusted net profit rose 46.6% year-over-year as EBITDA margin improved 80 bps to 21.6%. during the quarter.

Going ahead, the U.S., India and Russia generic formulations are expected to drive earnings. Analysts expect the stock to deliver 26% over the next one year.

Einen Kommentar schreiben

du mußt angemeldet sein, um kommentieren zu können.